On Monday, Inovio announced that it would be halting its phase 2/3 coronavirus vaccine trial so that it could continue to answer questions from the FDA. This comes as the MidWest of the United States starts to see coronavirus positive cases topping 25%. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus. …read more
Source:: Yahoo Finance
